The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Ketamine advertisements are popping up all around us. With few regulations in place, might we be witnessing another opioid epidemic?

Elon Musk discussed his use of ketamine for depression during an interview, claiming it helps him combat negative mental ...

Spravato has been approved since 2019 for TRD ... an intranasal formulation of racemic ketamine.

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

Stella Mental Health Westmont is a top depression and anxiety clinic near Chicago that offers comprehensive mental health treatments like Spravato (esketamine) therapy, ketamine infusion ...

Ketamine is often viewed more as a party drug than a medicine. One Columbia clinic is using the drug to help patients with ...

Spravato (esketamine) has possible interactions with alcohol, some other drugs, and certain supplements. Examples include Adderall and benzodiazepines such as clonazepam (Klonopin). Talk with your ...

Ketamine was first approved by the FDA as an anaesthetic in the 1970s and has been used for a long time in emergency and surgical settings. In 2019, esketamine (Spravato), derived from ketamine ...

However, it may cover Spravato, which contains esketamine. This is an FDA-approved drug that derives from ketamine and can help manage treatment-resistant depression. Despite not yet having FDA ...